Late-Breaking Studies Affecting Patient Outcomes I
Procalcitonin and NEWS2 Evaluation for Timely Identification of Sepsis and Optimal Use of Antibiotics in the Emergency Department (PRONTO): A Multicentre, Randomised, Controlled, Open-Label, Phase 3 Trial